Two studies showed that treatment with targeted therapy drugs (drugs that target the faulty genes and proteins that contribute to cancer growth) slowed the growth and spread of advanced NSCLC.

Patients with advanced non-small cell lung cancer (NSCLC) who received the drug pemetrexed (Alimta) as maintenance therapy (treatment given after chemotherapy to keep the cancer from growing and spreading) lived three to five months longer than patients who did not receive the drug, according to a new study.

Researchers found that most patients with metastatic colorectal cancer (cancer that has spread outside of the colon or rectum) do not need surgery to remove the primary tumor unless it is causing problems.

New research shows advances in the treatment of colorectal, anal, pancreatic, gastric, and rectal cancer.

A new study shows that patients who received a specialized treatment vaccine with interleukin-2 (IL-2; a standard treatment for advanced melanoma) for melanoma that has spread to other parts of the body lived almost five months longer than patients who received only IL-2.

Adding a cancer treatment vaccine to the standard treatment improved survival for children with neuroblastoma.

Researchers found that one in 10 patients participating in a clinical trial for colorectal cancer were concerned about paying for necessary supportive medications.

People with cancer who received ginger supplements along with drugs that lower nausea and vomiting, called antiemetics, reported less nausea from chemotherapy than patients who did not receive a ginger supplement.

Treatment with the drugs cisplatin (Platinol) and gemcitabine (Gemzar) increased survival and slowed cancer growth for people with biliary tract cancers (gallbladder and bile duct cancers) that could not be removed with surgery.

Researchers found that people with stage III or IV oropharyngeal cancer (cancer of the upper throat) who have tumors containing the human papillomavirus (HPV) live longer.